Dimensional Fund Advisors
ZNTL icon

Dimensional Fund Advisors’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Dimensional Fund Advisors’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.63M Buy
542,852
+270,818
+100% +$1.08M ﹤0.01% 2681
2026
Q1 		$634K Buy
272,034
+175,771
+183% +$454K ﹤0.01% 2914
2025
Q4 		$130K Sell
96,263
-88,769
-48% -$129K ﹤0.01% 3123
2025
Q3 		$279K Sell
185,032
-150,934
-45% -$226K ﹤0.01% 3076
2025
Q2 		$390K Sell
335,966
-111,434
-25% -$147K ﹤0.01% 3033
2025
Q1 		$712K Sell
447,400
-57,606
-11% -$124K ﹤0.01% 2945
2024
Q4 		$1.53M Sell
505,006
-638
-0.1% -$2.09K ﹤0.01% 2846
2024
Q3 		$1.86M Sell
505,644
-121,019
-19% -$440K ﹤0.01% 2794
2024
Q2 		$2.56M Sell
626,663
-96,993
-13% -$1.08M ﹤0.01% 2701
2024
Q1 		$11.4M Sell
723,656
-377
-0.1% -$5.19K ﹤0.01% 2258
2023
Q4 		$11M Buy
724,033
+239,714
+49% +$3.5M ﹤0.01% 2286
2023
Q3 		$9.72M Buy
484,319
+110,415
+30% +$2.8M ﹤0.01% 2276
2023
Q2 		$10.5M Buy
373,904
+51,107
+16% +$1.23M ﹤0.01% 2234
2023
Q1 		$5.55M Buy
+322,797
New +$6.54M ﹤0.01% 2453
2022
Q3 		$744K Sell
34,348
-37,362
-52% -$1.02M ﹤0.01% 2961
2022
Q2 		$2.01M Sell
71,710
-19,792
-22% -$524K ﹤0.01% 2736
2022
Q1 		$4.22M Buy
+91,502
New +$4.94M ﹤0.01% 2585

Other funds holding ZNTL

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Dimensional Fund Advisors's ZNTL Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Zentalis Pharmaceuticals (ZNTL) stake by 100% in Q2 2026, buying an estimated $1.08M and bringing the position to 542,852 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2681.

Dimensional Fund Advisors first reported a position in ZNTL in Q1 2022 and has held it in 17 quarters since. The position peaked at $11.4M in Q1 2024. 114 funds tracked by Wall St. Rank hold ZNTL as of Q2 2026.

  • Dimensional Fund Advisors held 542,852 shares of Zentalis Pharmaceuticals worth $2.63M as of Q2 2026.
  • Dimensional Fund Advisors bought 270,818 Zentalis Pharmaceuticals shares in Q2 2026, an estimated $1.08M.
  • Zentalis Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2681 holding.
  • Dimensional Fund Advisors first reported a position in Zentalis Pharmaceuticals in Q1 2022 and has held it in 17 quarters since.
  • Dimensional Fund Advisors's Zentalis Pharmaceuticals position peaked at $11.4M in Q1 2024.
  • 114 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.